Global DrugAbuse Treatment Market, by Abuse Type (Alcohol Dependence, Tobacco/NicotineAddiction, and Opioid Addiction), by Drug Type (Disulfiram, Acamprosate,Naltrexone, Methadone, Buprenorphine, Nicotine Addiction Treatment ((NicotineReplacement Treatment (Nicotine Patch, Nicotine Gum, Nicotine Lozenge, NicotineSpray, and Nicotine Inhaler)) ((Non-Nicotine Medication, (Bupropion, and Varenicline)),and Others), by Distribution Channel (Hospital, Retail Pharmacy, and OnlinePharmacy) and by Region (North America, Latin America, Europe, Asia Pacific,the Middle East, and Africa) was valued at US$ 13.4 Bn in 2017, and isprojected to exhibit a CAGR of 7.8% over the forecast period (2018 – 2026).
Increasing launches of noveldrugs for treatment of drug abuse in market is expected to drive the globaldrug abuse treatment market growth in near future. For instance, in 2015, MylanN.V. launched its new drugs Disulfiram Tablets USP, 250 mg and 500 mg in theU.S. market, drugs Disulfiram Tablets USP is a generic version of OdysseyPharmaceutical's Antabuse. In 2017, Glenmark Pharmaceuticals launched its newnicotine replacement therapy namely Kwitz in India. Kwitz is a nicotine gum andis available in two variants Kwitz 2 mg and Kwitz 4 mg. Kwitz 2 mg is for thesmokers having less than 20 cigarettes per day and Kwitz 4 mg is for those whosmoke more than 20 cigarettes per day. In April 2018, Lil' Drug Store ProductsInc. launched its Nicotac brand nicotine gum in market. Lil' Drug StoreProducts Inc. has launched its Nicotac in two nicotine strengths (2 mg and 4 mgnicotine polarcrilex). In 2017, Cipla Health, an arm of Cipla Limited launcheda new Nicotex Nicotine Patches. Nicotex Nicotine Patches are skin/transdermalpatches, which helps to quit smoking in 12 months. Company has launched itspatches in 3 strengths 21 mg, 14 mg, and 7 mg. 21 mg patch is for one who smokemore than 20 cigarette a day, 14 mg is for those who smoke less that 20cigarette a day
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2011
Browse 23 Market Data Tables and26 Figures spread through 180 Pages and in-depth TOC on Drug Abuse TreatmentMarket By Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, andOpioid Addiction), By Drug Type (Disulfiram, Acamprosate, Naltrexone,Methadone, Buprenorphine, Nicotine Addiction Treatment ((Nicotine ReplacementTreatment (Nicotine Patch, Nicotine Gum, Nicotine Lozenge, Nicotine Spray,Nicotine Inhaler)) ((Non-Nicotine Medication, (Bupropion, and Varenicline)),and Others), By Distribution Channel (Hospital, Retail Pharmacy, and OnlinePharmacy) and Region (North America,Latin America, Europe, Asia Pacific, the Middle East, and Africa) - GlobalForecast to 2026
Furthermore, increasingprevalence of drug abuse and dependence in key regions are expected to increasethe demand for its treatment and management drugs in near future. For instance,according to the Substance Abuse and Mental Health Services Administration(SAMHSA), around 830,000 people in the U.S. used heroin in 2015, which is morethan double the number from 2002. Such increasing rates of drugs abuse areexpected to fuel growth of the global drug abuse treatment market in nearfuture.
Key Takeaways of the Drug AbuseTreatment Market:
The global drug abuse treatmentmarket is expected to exhibit a CAGR of 7.8% over the forecast period (2018 –2026), owing to frequent product launches, approval and robust pipeline ofnovel biopharmaceutical products
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/drug-abuse-treatment-market-2011
North America held the dominantposition in the global drug abuse treatment market and is expected to retainits dominance over the forecast period (2018 – 2026). This is due to the highrates of drug abuse in region, which are expected to increase demand for itstreatment drugs over the forecast period. For instance, according to the datapublished by National Institute of Alcohol abuse and Alcoholism in 2015, around15.1 million adults ages 18 and older (6.2 percent of this age group) aresuffering from Alcohol Use Disorder. This includes 9.8 million men (8.4 percentof men in this age group) and 5.3 million women
Asia Pacific is expected towitness significant growth over the forecast period due to increasing launchesof novel drugs by key players in the region. For instance, in 2017, GlenmarkPharmaceuticals launched a new Kwitz is a nicotine gum in India.
Major players operating in thedrug abuse treatment market include Cipla Limited, Glenmark Pharmaceuticals,Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store ProductsInc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical IndustriesLtd., and British American Tobacco Plc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2011
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
